Axiom

Axiom is the culmination of complete injection pen design, incorporating a unique dosage mechanism that has led to the development of new intellectual property.

Axiom is the result of the Shaily Innovations team developing an Injection Pen capable of administering various medical treatments. Our key objective was to create an affordable, patient-friendly injection pen that Shaily could produce and offer to pharmaceutical companies to sell as their own drug delivery device.

The product needed to be capable of delivering a wide variety of treatments such as Teriparatide, Human Growth Hormone (HGH), Follicle Stimulating Hormone (FSH), Glucagon-Like Peptide-1 (GLP-1), and more. Each device would deliver a daily drug dose over a 28-day period.

Our engineers worked closely with our designers to ensure the best design for patients, with the final pen offering a discreet, quick and easy dosage system for users. Safety of drug delivery was a key focus of the design and the device was designed with features to ensure it was completely fail-safe and protected against user error. A pull-to-dose mechanism was developed that ensured it would only release medication when it was correctly used.

Shaily Innovations constantly seeks to develop devices with distinctive intellectual property. This is an important consideration as drug delivery devices have a history of development challenges with many of the mechanisms being patent-protected.

Prototypes were made throughout the development of Axiom. Rapidly developed SLA prototypes were invaluable in refining the form and testing mechanisms in a realistic way. Shaily Innovations were responsible for the entire product development lifecycle, providing testing and verification with partners across Europe. Full traceability and documentation were provided to achieve medical certification in Europe and the US. This included FDA and the ISO 11608 quality standard.

The pens are manufactured almost entirely from medical grade plastics in Shaily’s world-class facilities, with a combination of PC, PCM, PC/ABS and glass-filled materials. The Axiom injector platform is already enjoying commercial success thanks to the combination of Shaily Innovations unique IP and our high-quality manufacturing